bone loss
Zoeken
Gevonden resultaten: 1
Prolia® (denosumab) Arriving Worldwide for the treatment of postmenopausal osteoporosis — ... « bone-loss
(Klikken: 150;website toegevoegd: Mar 24, 2014, bone-loss)
Prolia® (denosumab), the first and only approved RANK Ligand inhibitor, has filed for approval worldwide for the treatment of postmenopausal osteoporosis.
prolia denosumab rank ligand rank ligand inhibitor bone loss